Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders

被引:23
作者
Hemsley, Kim M. [1 ,2 ]
Hopwood, John J. [1 ,2 ]
机构
[1] Womens & Childrens Hosp, Lysosomal Dis Res Unit, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia
关键词
MUCOPOLYSACCHARIDOSIS TYPE IIIA; ENZYME-REPLACEMENT THERAPY; NEURONAL CEROID-LIPOFUSCINOSIS; SUBSTRATE REDUCTION THERAPY; MOUSE MODEL; SANFILIPPO-SYNDROME; GENE-THERAPY; MPS-IIIA; GM2; GANGLIOSIDOSIS; HUNTAWAY DOGS;
D O I
10.1007/s10545-010-9078-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Approximately 50 inborn errors of metabolism known as lysosomal storage disorders have been discovered to date, most of which are due to a single mutation in a gene encoding a soluble lysosomal enzyme. Consequently, inadequate enzyme activity results in the accumulation of substrates for that enzyme, invariably accompanied by a wide variety of secondary pathological changes. Many of these conditions remain untreatable, and therefore, research into pathogenic processes and potential treatment strategies is intense. A key tool for researchers in this area is the availability of clinically relevant animal models in which to study disease manifestation and evaluate therapeutic outcomes. Large numbers of both naturally occurring and genetically modified animal models of neurodegenerative lysosomal storage disorders are in existence, with spontaneous models occurring in both large domestic (e.g., cat, dog, sheep) and small (e.g., mouse) animal species. Many have undergone rigorous phenotypic characterization and are now providing us with insights into neurological disease processes. The purpose of this review is to highlight some of the major lessons learnt from these studies.
引用
收藏
页码:363 / 371
页数:9
相关论文
共 104 条
[1]   CLINICAL, NEUROPHYSIOLOGICAL, BIOCHEMICAL AND MORPHOLOGICAL FEATURES OF EYES IN PERSIAN CATS WITH MANNOSIDOSIS [J].
ALROY, J ;
BACHRACH, A ;
THALHAMMER, JG ;
PANJWANI, N ;
RICHARD, R ;
DEGASPERI, R ;
WARREN, CD ;
ALBERT, DM ;
RAGHAVAN, SS .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1991, 60 (03) :173-180
[2]   Skin biopsy: A useful tool in the diagnosis of lysosomal storage diseases [J].
Alroy, Joseph ;
Ucci, Angelo A. .
ULTRASTRUCTURAL PATHOLOGY, 2006, 30 (06) :489-503
[3]  
AUER IA, 1995, ACTA NEUROPATHOL, V90, P547
[4]   Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice [J].
Ausseil, Jerome ;
Desmaris, Nathalie ;
Bigou, Stephanie ;
Attali, Ruben ;
Corbineau, Sebastien ;
Vitry, Sandrine ;
Parent, Mathieu ;
Cheillan, David ;
Fuller, Maria ;
Maire, Irene ;
Vanier, Marie-Therese ;
Heard, Jean-Michel .
PLOS ONE, 2008, 3 (05)
[5]   INHIBITION OF LEUKOCYTIC LYSOSOMAL ENZYMES BY GLYCOSAMINOGLYCANS INVITRO [J].
AVILA, JL ;
CONVIT, J .
BIOCHEMICAL JOURNAL, 1975, 152 (01) :57-64
[6]   Behavioral phenotyping of transgenic and knockout mice: Practical concerns and potential pitfalls [J].
Bailey, KR ;
Rustay, NR ;
Crawley, JN .
ILAR JOURNAL, 2006, 47 (02) :124-131
[7]   NEURONAL GM1 GANGLIOSIDOSIS IN A SIAMESE CAT WITH BETA-GALACTOSIDASE DEFICIENCY [J].
BAKER, HJ ;
LINDSEY, JR ;
MCKHANN, GM ;
FARRELL, DF .
SCIENCE, 1971, 174 (4011) :838-&
[8]   Canine models for human genetic neurodegenerative diseases [J].
Barsoum, SC ;
Callahan, HM ;
Robinson, K ;
Chang, PL .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (05) :811-823
[9]  
BASKIN G, 1989, LAB INVEST, V60, pA7
[10]   A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant [J].
Bhattacharyya, R ;
Gliddon, B ;
Beccari, T ;
Hopwood, JJ ;
Stanley, P .
GLYCOBIOLOGY, 2001, 11 (01) :99-103